A startup that wants to take cancer therapy to the next level just landed a $2.5 billion deal ($celg)
A startup that wants to take cancer therapy to the next level just landed a $2.5 billion deal ($celg)
Celgene is investing in Jounce Therapeutics, a a biotech startup that's trying to pave the way for the next set of cancer immunotherapy drugs.
Source:
www.businessinsider.com
You've added this content to your favorites.
Post your comment
Load More
